Investment Confidence Among Laboratory Decision Makers
This Frost & Sullivan research service titled Investment Confidence Among Laboratory Decision Makers analyzes laboratory decision makers’ investment confidence in laboratory-related purchases, based on past spending trends and future financial expectations. More specifically, the research strives to assess present and future business conditions, evaluate levels of confidence in possible business scenarios, as well as research present and future budget changes. In this research, Frost & Sullivan's expert analysts thoroughly examine the following technologies: cell biology, microbiology, polymerase chain reaction, cell based assays, laboratory information management systems, and DNA microarrays.
This analysis is available through our Clinical Diagnostics Growth Partnership Services program. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services program ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth. For more information on this custom subscription service, please click here.
Laboratory Decision Makers Cautiously Optimistic about Funding Conditions in 2012
Surveys Show a Marginal Year-on-Year Increase in the Number of Decision Makers that Expect the Current Q4 to be Better than the Previous Q4
The laboratory industry rode a roller coaster in 2011, with the economic recovery and the residual dollars of the 2009 American Recovery and Reinvestment Act (ARRA) funding. By 2011 fourth quarter (Q4), the market began to soften with hiring freezes and deterioration of most purchasing budgets. In 2012, laboratory decision makers expect their funding conditions to either remain the same or improve marginally. They believe they will have adequate funds to maintain a proper work environment and acquire the necessary technology to achieve their research objectives. This modestly optimistic outlook is rooted in the responses of 35 percent of laboratory decision makers who believe that business conditions during Q4 2012 will be better than those in Q4 2011. This is a small yet noteworthy increase over the 31 percent who believed that business conditions in Q4 2011 were better than they were during Q4 2010. “While 42 percent believe that from Q4 2010 through Q4 2012, there will be no change to business conditions, those who believe conditions will be worse decreased from 21 percent to 15 percent,” says the analyst of this research. “Laboratory decision makers certainly do not expect 2012 to be a vast improvement over 2011; however, they do expect some changes for the better.”
The biggest budget cuts from 2010 to 2011 were in furniture, construction, and hiring, and budgets for infrastructure and staff are expected to face similar drops in 2012. The ARRA funding was channeled toward the development of multiple new laboratories; therefore, further investments in construction and infrastructure in 2012 will be unlikely. Even research budgets did not change substantially from 2010 to 2011. The most significant mean budget hikes were in the areas of commodities, supplies, and consumables, while the steepest mean budget reduction was for additional and replacement staff. “Although 2008 to 2011 were unstable for the laboratory industry, some may argue the survivors emerged leaner and more committed to progressing research and development,” notes the analyst. “Moreover, the economic turmoil served as a learning experience on staying afloat when faced with limited funding.” Given current expectations from 2012, laboratories can certainly put that education to good use.
The following technologies are covered in this research:
- Cell Biology
- Polymerase chain reaction
- Cell based assays
- Laboratory information management systems
- DNA microarrays
Frost & Sullivan Growth Partnership Services
Frost & Sullivan's Growth Partnership Services empower companies to accelerate their growth by achieving top-line improvements and bottom-line results. This is accomplished by helping our clients execute successful growth strategies and providing their Growth Teams™ with the skills, know-how, and tools to generate growth opportunities, evaluate these opportunities to create a growth pipeline, and implement a growth strategy to deliver measurable business results.
Our growth solutions support the entire growth process:
TEAM Research is a program that furnishes clients with access to market research, competitive intelligence, financial benchmarking, and market strategies and analysis, and provides access to industry experts to aid in generating growth opportunities.
Growth Consulting Services unite clients with our industry experts to evaluate opportunities and develop customized strategies and business plans to drive top-line revenue and margin growth.
Growth Team Membership™ is a career-focused offering that was developed to address the unique challenges that senior executives face when implementing strategies to achieve aggressive corporate growth targets.